Clinical Trials Browser

Phase 2 × sapacitabine × Thoracic × Clear all

NCT00885963 2021-12-22

A Study of Oral Sapacitabine in Patients With Previously Treated Non-Small Cell Lung Cancer

Phase 2 Terminated

Carcinoma, Non-Small-Cell Lung